News
-
The self-proclaimed ‘business jet fuel’ 14-week program is open for applications until the 8th August 2021.Article -
BioNTech has announced entering into a purchase agreement with Kite to acquire its solid tumour neoantigen TCR R&D platform and clinical...Article -
The MONACO study is reported to be the first Phase I trial for the condition, and is based in London, UK.Article -
The acquisition is reported to expand the companies’ presence in the ATMP market.Article -
The acquisition – pending final due diligence – is expected to significantly expand AGC Biologics’ cell and gene therapy capabilities.Article -
The acquisition will expand Sartorius’ cell and gene portfolio with cell culture components, such as growth factors, cytokines and media.Article -
Following the recent announcement that Charles River intended to acquire Vigene Biosciences to enhance the company’s gene therapy offerings, the...Article -
Intellia Therapeutics and Regeneron have announced positive interim clinical data following the administration of an investigational CRISPR therapy,...Article -
A new agreement between Lonza and CellPoint will reportedly seek to rapidly develop several T-cell therapies for point-of-care manufacturing, aiming...Article -
France-based Mnemo Therapeutics has announced completion of its €75 million Series A financing, allowing acceleration of the development of an...Article -
Inceptor Bio has announced the launch of a new platform dedicated to advancing cell and gene therapies for hard-to-treat cancers.Article -
A team from St Jude Children’s Research Hospital has explored the costs associated with manufacturing and distributing a severe haemophilia B gene...Article -
A new virtual reality (VR) training opportunity could reportedly reduce the time and costs associated with training new employees in advanced...Article -
Cytiva and Multiply Labs have announced a collaboration to develop a robotic manufacturing system to automate portions of the cell therapy...Article -
For this new monthly column, Georgi Makin summarises some of her top picks from clinical news in cell and gene therapy.Article -
![[MEET OUR PARTNER] Introducing The Cell + Gene Curator](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/corporate_work_blog_banner_13.png?itok=XBmJtc5_)
We are pleased to be working with the Medicine Maker and Cell + Gene Curator to accelerate the Phacilitate mission of helping to advance the next...Article -
Thermo Fisher Scientific (MA, USA) has announced a ‘strategic alliance’ with the University of California, San Francisco (UCSF; CA, USA) to...Article -
A new collaboration between Ginkgo Bioworks and Biogen (both MA, USA) has been announced that aims to develop a novel, next-...Article -
A new research agreement, funded by ONK Therapeutics (Galway, Ireland) and based at the National University of Ireland, Galway (NUI Galway...Article -
![[NEWS] C-Stem™ outperforms 2D & aggregate cultures in benchmark of cell culture technologies for the mass-production of human induced pluripotent stem cells](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/treefrog-therapeutics-exponential-ips-cell-expansion-in-large-scale-bioreactor-preserved-cell-quality-1536x1024.jpg?itok=KJQpm6bu)
TreeFrog Therapeutics presents new data at the American Society for Cell & Gene Therapy 24th Annual MeetingArticle -
SOLUPORE® technology enables the next-generation of gene-modified cell therapiesArticle -
![[NEWS] AVECTAS Leads €7.23 million Consortium Awarded Part Funding From Ireland’s Disruptive Technologies Innovation Fund](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/avectas.jpg?itok=HDQb9AYC)
The project, led by Avectas in partnership with Bluebridge Technologies and National Institute for Bioprocessing Research and Training (NIBRT), would...Article -
![[NEWS] ATTC network establishes first Advanced Therapies NHS Readiness Toolkit](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/attc_logo.png?itok=a0gVsOGZ)
The toolkit will enable widespread clinical adoption and improved patient access to advanced therapies across the UKArticle -
![[NEWS] Lykan Bioscience Welcomes Kenneth LeClair as Chief Technology Officer](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/lykan_2_color_rgb_0.png?itok=gKweAy77)
Lkan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the...Article -
![[NEWS] Lykan Bioscience Appoints Industry Leader Patrick Lucy as President & CEO](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/plucy_headshot_revised2_0.jpg?itok=AKbl_9uq)
Patrick in the new role will also join Lykan's board of directorsArticle -
![[NEWS] Akron Biotech appoints new Scientific Advisory Board, further expanding its cell and gene therapy industry expertise](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/photo-1431540015161-0bf868a2d407.jpg?itok=XhShAw6D)
The new board is comprised of 6 leading figures from within the cell and gene therapy field.Article -
![[NEWS] Sexton Biotechnologies, Hitech Health, and Med Institute Announce Collaboration to Demonstrate the Benefits of Flexible Automation](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/sexton-bio-home-page-logo.png?itok=tPMy7pQ4)
Their collaboration will develop and publish workflows for integrating unit operations in cell therapy manufacturing using flexible automation...Article -
Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Novel Immunomagnetic Cell Separation Platform to Bioseparation PortfolioArticle -
[PRESS RELEASE] Lykan Bioscience, a contract Manufacturing Organization (MSO), welcomes Keith McCormick as Chief Financial OfficerArticle -
Phacilitate has confirmed that Advanced Therapies Week, which was originally planned for this January, will take place as a live show in June 2021...Article -
Partnership Aims to Enhance Safety of Human Serum from Viruses Such as the Virus that Causes COVID-19Article -
“Patrick’s background and expertise aligns well with Lykan’s Mission, to partner with our clients to maximize patient accessibility and expedite time...Article -
EmendoBio to operate as an independent subsidiary of AnGes with full access to global development resources to accelerate development and...Article -
RheinCell Therapeutics offers fully characterized clinical-grade iPSCs for cell therapy development and commercializationArticle -
The National Horizons Centre, RoslinCT and the University of Birmingham will deliver cell and gene therapy and vaccine manufacturing specific on-site...Article -
The Standards Coordinating Body (SCB) is proud to announce that another SCB-coordinated standard project has culminated in the publication of a...Article -
and Full Exercise of the Underwriters’ Option to Purchase Additional SharesArticle -
![[BLOG] The State of Cell and Gene Therapy Content Marketing: Five trends that will get you noticed in 2021](https://www.phacilitate.co.uk/sites/default/files/styles/three_block_list__360_x_240_/public/clarion_phacilitate/content_types/articles/pexels-photo-355948.jpeg?itok=RsG_VgBR)
THE FIRST POST IN A NEW CONTENT MARKETING BLOG SERIES, SARAH ROSENBERG, HEAD OF MARKETING AT PHACILITATE SHARES WHAT TRENDS WILL GET YOU NOTICED IN...Article -
The two organisations today announced a strategic partnership to accelerate production for the clinical development of VG901, a next-generation...Article -
Technology targets critical shortage of viral vectors for the rapidly expanding field of cell and gene therapeuticsArticle -
Most significant increases in expansion of gene therapy and viral vector manufacturing spacesArticle -
OrganaBio's cell and gene therapy manufacturing facility is slated to commence operations in Q3 2021Article -
The new laboratory will increase industry testing capacity for cell and gene therapies, enabling faster and more effective development, manufacturing...Article -
The agreement enables drug developers to leverage both companies expertise and technologies for the generation of human-induced pluripotent stem...Article -
Cellares is on a Mission to Accelerate Access to Life-saving Cell Therapies Under the Collaboration, Fred Hutch Will Provide Input and Share...Article -
New Plasmid DNA production platform enables cell and gene therapies to be developed, manufactured and released faster and with greater predictability.Article -
CCRM AND MIP ANNOUNCE THEY HAVE EXECUTED A LETTER OF INTENT TO PARTNER IN THE DEVELOPMENT AND OPERATION OF A BIOMANUFACTURING CAMPUS AT MCMASTER...Article -
Akron Biotechnology announces it has signed an agreement for the provision of SNG001, Synairgen’s wholly-owned inhaled interferon beta (IFN-beta)...Article -
Syndicate led by leading life science investors Northpond Ventures alongside Octopus VenturesArticle -
Lab to support researchers developing new treatments for global healthcare marketArticle -
The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier and Jennifer A....Article -
OrganaBio announces the launch of the MesenPAC™ and ImmunoPAC™ product lines, designed to support translational researchers in their quest to rapidly...Article -
The global cell and gene therapy community will now unite in June 2021Article -
Stemson Therapeutics secure $7.5 million seed financing led by Allergan Aesthetics, an AbbVie Company, and impact investor Fortunis CapitalArticle -
A national leader in pediatric oncology research and treatment, Dr Laetsch will also lead CHOP's Developmental Therapeutics ProgramArticle -
Breakthrough automation technology for cell therapy products to enable scale-up of production volumes and reduction of production costsArticle -
Non-dilutive debt; no amortisation for seven months; maturity of 21 MonthsArticle -
Phase I/II study in patients with solid tumours expected to commence in Q3 2020 at leading sites in the United StatesArticle -
Tessa Therapeutics announces results from two independent phase I/II trials of autologous CD30 CAR-T cell therapy in patients with relapsed or...Article -
Dr Davidson, a lipidology expert, joins the board at CaladriusArticle -
Kite Becomes the First Company with Multiple Approved CAR T TherapiesArticle -
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investmentArticle -
Leading-edge, comprehensive electronic format master files for IL-2, IL-7, IL-15, and IL-21 provide transparency and regulatory support for cell and...Article -
An update on Phacilitate's rebrand activitiesArticle -
Details of the agreement between Moderna and CatalentArticle -
A statement on the future of the World Stem Cell Summit and Phacilitate's Advanced Therapies Week 2021Article -
Cobra Biologics is providing large scale manufacturing capacity for AZD1222Article -
The collaboration will see Achilles Therapeutics expand their manufacturing footprint at the CGT Catapult manufacturing centre to supply clinical...Article -
Alligator Bioscience and Scandion Oncology collaborate on combination therapy to treat previously resistant cancer cellsArticle -
CCRM and Cytiva, formerly part of GE Healthcare Life Sciences, renew collaboration agreement for Centre for Advanced Therapeutic Cell TechnologiesArticle -
Data completion process is nearing the finish lineArticle -
Oxford Biomedica and AstraZeneca agree partnership to manufacture Covid-19 vaccine candidateArticle -
World-class platform will enable biotechnology companies and researchers to accelerate the development, manufacturing and release of cell and gene...Article -
The companies will combine their expertise to explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative...Article -
The collaboration will leverage Avectas’ cell engineering technology and ONKs Death Receptor TRAIL variantArticle -
CCRM and GE Healthcare Life Sciences develop proprietary media formulations for Platelet BioGenesisArticle -
HemaCare launch new GMP-compliant bone marrow starting materialArticle -
Phacilitate's new initiative, Advanced Therapies Week incorporates Phacilitate Leaders World, the World Stem Cell Summit and a brand new creative...Article -
Transformative acquisition creates global cell and gene therapy manufacturing services platform for both clinical and commercial productsArticle -
An expansion of advanced therapies manufacturing capacity in the European marketArticle -
EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journeyArticle -
Medace will be moving to Brightlands Maastricht Health Campus in January 2020 where it will reside in a brand new, state of the art GMP-ready...Article -
New rocking motion single-use bioreactor system to culture cell products in working volumes up to 5 L and Flexsafe® RM TX bags premier at...Article -
EXELLULA, the new Italian industrial complex entirely dedicated to the production of cell and gene therapies, will be a centre of excellence for...Article -
Novel Packaging and Expression Plasmids Promise to Reduce Gene Therapy Manufacturing Costs and Delivery TimesArticle -
FloDesign Sonics announce the commercial launch of their first product within the ekko platform line to support the needs of cell and gene therapy...Article -
Clinical trials around adipose-derived regenerative cells focus of programArticle -
Anemocyte sponsor Phacilitate:TALKS, a new stage at Phacilitate Leaders World 2019Article -
VIVEbiotech receives the Technological Innovation SME Award at the Pyme Awards in Madrid, SpainArticle -
A brand new partnership between the Emily Whitehead Foundation and PhacilitateArticle -
State-of-the-art facility to meet industry demand for high-quality GMP cellular materialArticle -
Press release from Vineti, Inc.Article
![[Q&A] Expanding Capacity and Talent in the Cell and Gene Therapy Industry (38807)](https://www.phacilitate.co.uk/sites/default/files/styles/thumbnail/public/sidebar_editor_pick/corporate_work_blog_banner_12.png?itok=zBvgIw1c)
